Gilead Sciences, Inc. (NEO:GILD)
24.50
-0.12 (-0.49%)
Aug 15, 2025, 4:00 PM EDT
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of CAD 202.75 billion as of August 15, 2025. Its market cap has increased by 54.89% in one year.
Market Cap
202.75B
Enterprise Value
226.06B
Revenue
39.37B
Ranking
n/a
PE Ratio
23.56
Stock Price
24.50
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 289.43M to 202.75B, an increase of 69,949.43%. That is a compound annual growth rate of 21.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 15, 2025 | 202.75B | 22.41% |
Dec 31, 2024 | 165.64B | 24.25% |
Dec 29, 2023 | 133.31B | -8.53% |
Dec 30, 2022 | 145.73B | 26.44% |
Dec 31, 2021 | 115.26B | 23.86% |
Dec 31, 2020 | 93.06B | -12.73% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Curaleaf Holdings | 2.87B |
Green Thumb Industries | 2.62B |
Trulieve Cannabis | 1.98B |
Sienna Senior Living | 1.75B |
dentalcorp Holdings | 1.61B |
Cronos Group | 1.35B |
WELL Health Technologies | 1.22B |
Extendicare | 1.13B |